288 related articles for article (PubMed ID: 23683774)
1. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
[TBL] [Abstract][Full Text] [Related]
2. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
3. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
[TBL] [Abstract][Full Text] [Related]
4. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
5. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
Li W; Yang S; Qiao R; Zhang J
Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
[TBL] [Abstract][Full Text] [Related]
6. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
7. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
Nossier AI; Shehata NI; Morsy SM; Saeed DF; Elsayed NM; Ismail MF; Eissa S
Anal Biochem; 2020 Nov; 609():113967. PubMed ID: 32950495
[TBL] [Abstract][Full Text] [Related]
8. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
9. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
Simpson K; Wonnacott A; Fraser DJ; Bowen T
Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
[TBL] [Abstract][Full Text] [Related]
11. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.
El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH
J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120
[TBL] [Abstract][Full Text] [Related]
12. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
Kishore L; Kaur N; Singh R
Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
[TBL] [Abstract][Full Text] [Related]
13. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.
Jia Y; Guan M; Zheng Z; Zhang Q; Tang C; Xu W; Xiao Z; Wang L; Xue Y
J Diabetes Res; 2016; 2016():7932765. PubMed ID: 26942205
[TBL] [Abstract][Full Text] [Related]
14. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
15. Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease.
Zhao Y; Shen A; Guo F; Song Y; Jing N; Ding X; Pan M; Zhang H; Wang J; Wu L; Ma X; Feng L; Qin G
Front Endocrinol (Lausanne); 2020; 11():590. PubMed ID: 32982978
[TBL] [Abstract][Full Text] [Related]
16. Urinary microRNA profiling in the nephropathy of type 1 diabetes.
Argyropoulos C; Wang K; McClarty S; Huang D; Bernardo J; Ellis D; Orchard T; Galas D; Johnson J
PLoS One; 2013; 8(1):e54662. PubMed ID: 23358711
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
Kato M; Natarajan R
Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
[TBL] [Abstract][Full Text] [Related]
19. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes.
Abdelghaffar S; Shora H; Abdelatty S; Elmougy F; El Sayed R; Abdelrahman H; Soliman H; Algebaly H; Ahmed S; Alfy P; Elshiwy Y
Diabetes Metab Syndr Obes; 2020; 13():2485-2494. PubMed ID: 32765027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
